SMDM 2026 · QMTD

Using a stochastic epidemic model to guide efficient seroprevalence sampling decisions

Supun Manathunga1 · Nathaniel Osgood2 · Sheila O'Brien3 · David L Buckeridge1,4 · W. Alton Russell1,4

1Division of Experimental Medicine, McGill University   2University of Saskatchewan   3Canadian Blood Services   4School of Population and Global Health, McGill University

Poster supplement — data description, ethics statement, and references for Manathunga et al., Adaptive sample size design for serological surveillance during an epidemic using particle filter predictions.

Data

During the COVID-19 serosurveillance program, Canadian Blood Services (CBS) tested residual EDTA plasma retention samples from blood donors using different antibody assays as the pandemic evolved. In the early phase of surveillance (mid-2020), samples were screened for IgG antibodies against the SARS-CoV-2 nucleocapsid (N) protein using the Abbott Architect SARS-CoV-2 IgG chemiluminescent microparticle immunoassay (CMIA) on Abbott Architect immunoassay analyzers, allowing detection of antibodies generated following natural infection.

As vaccination campaigns began in 2021 and the need arose to distinguish infection-induced from vaccine-induced immunity, CBS adopted a dual-assay approach using the Roche Elecsys Anti-SARS-CoV-2 spike semi-quantitative immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland), measuring total antibodies (IgA, IgM, IgG) to the SARS-CoV-2 S1/receptor-binding domain (anti-S), together with the Roche Elecsys Anti-SARS-CoV-2 qualitative immunoassay measuring total antibodies to the nucleocapsid antigen (anti-N).

We used serological data spanning May 2020 through November 2023, comprising 1,103,191 weekly serological records from 448,241 unique blood donors across 9 Canadian provinces, grouped into four modeled regions. Strata were defined by province, sex, and age group (18–26, 27–36, 37–46, 47–56, and 57+ years), with stratum population sizes drawn from Statistics Canada.

Region Records Unique donors Anti-N n Anti-S n
Atlantic102,03341,844102,03385,610
Prairies317,448125,034317,448286,128
British Columbia183,11876,428183,118166,939
Ontario500,592204,935500,592429,180
Total1,103,191448,2411,103,191967,857

Ethics statement

The SARS-CoV-2 serosurveillance study was approved by the Research Ethics Board of Canadian Blood Services. This secondary analysis was approved by the Faculty of Medicine & Health Sciences Research Ethics Board Office, McGill University, Montreal, Canada (REB number 22-03-077).

References

  1. Müller SA, Agweyu A, Akanbi OA, et al. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response. The Lancet. 2023;402(10399):356–358. doi:10.1016/S0140-6736(23)00964-9
  2. Haselbeck AH, Im J, Prifti K, Marks F, Holm M, Zellweger RM. Serology as a tool to assess infectious disease landscapes and guide public health policy. Pathogens. 2022;11(7):732. doi:10.3390/pathogens11070732
  3. Fosgate GT. Practical sample size calculations for surveillance and diagnostic investigations. Journal of Veterinary Diagnostic Investigation. 2009;21(1):3–14. doi:10.1177/104063870902100102
  4. Stringhini S, Zaballa M-E, Pullen N, et al. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nature Communications. 2021;12:3455. doi:10.1038/s41467-021-23796-4
  5. Franceschi VB, Santos AS, Glaeser AB, et al. Population-based prevalence surveys during the Covid-19 pandemic: a systematic review. Reviews in Medical Virology. 2021;31(4):e2200. doi:10.1002/rmv.2200
  6. Daza-Torres ML, Capistrán MA, Capella A, Christen JA. Bayesian sequential data assimilation for COVID-19 forecasting. Epidemics. 2022;39:100564. doi:10.1016/j.epidem.2022.100564
  7. Doucet A, de Freitas N, Gordon N. An introduction to sequential Monte Carlo methods. In: Sequential Monte Carlo Methods in Practice. Springer; 2001:3–14. doi:10.1007/978-1-4757-3437-9_1
  8. Zuo J-Y, Jia Y-N, Zhang Y-Z, Lian W. Adaptive iterated particle filter. Electronics Letters. 2013;49(12):742–744. doi:10.1049/el.2012.4506
  9. Gordon NJ, Salmond DJ, Smith AFM. Novel approach to nonlinear/non-Gaussian Bayesian state estimation. IEE Proceedings F (Radar and Signal Processing). 1993;140(2):107–113. doi:10.1049/ip-f-2.1993.0015
  10. Liu JS. Blind deconvolution via sequential imputations. Journal of the American Statistical Association. 1995;90(430):567–576. doi:10.1080/01621459.1995.10476552
  11. Kong A, Liu JS, Wong WH. Sequential imputations and Bayesian missing data problems. Journal of the American Statistical Association. 1994;89(425):278–288. doi:10.1080/01621459.1994.10476469
  12. Dukić V, Lopes HF, Polson NG. Tracking epidemics with Google flu trends data and a state-space SEIR model. Journal of the American Statistical Association. 2012;107(500):1410–1426. doi:10.1080/01621459.2012.713876
  13. Yang W, Lipsitch M, Shaman J. Inference of seasonal and pandemic influenza transmission dynamics. Proceedings of the National Academy of Sciences. 2014;111(26):9684–9689. doi:10.1073/pnas.1415012111
  14. Funk S, Camacho A, Kucharski AJ, Eggo RM, Edmunds WJ. Real-time forecasting of infectious disease dynamics with a stochastic semi-mechanistic model. Epidemics. 2018;22:56–61. doi:10.1016/j.epidem.2016.11.003
  15. He D, Ionides EL, King AA. Plug-and-play inference for disease dynamics: measles in large and small populations as a case study. Journal of the Royal Society Interface. 2010;7(43):271–283. doi:10.1098/rsif.2009.0151
  16. Dureau J, Kalogeropoulos K, Baguelin M. Capturing the time-varying drivers of an epidemic using stochastic dynamical systems. Biostatistics. 2013;14(3):541–555. doi:10.1093/biostatistics/kxs052
  17. Liu J, West M. Combined parameter and state estimation in simulation-based filtering. In: Sequential Monte Carlo Methods in Practice. Springer; 2001:197–223. doi:10.1007/978-1-4757-3437-9_10
  18. Ionides EL, Nguyen D, Atchadé Y, Stoev S, King AA. Inference for dynamic and latent variable models via iterated, perturbed Bayes maps. Proceedings of the National Academy of Sciences. 2015;112(3):719–724. doi:10.1073/pnas.1410597112
  19. King AA, Nguyen D, Ionides EL. Statistical inference for partially observed Markov processes via the R package pomp. Journal of Statistical Software. 2016;69(12):1–43. doi:10.18637/jss.v069.i12
  20. Snyder C, Bengtsson T, Bickel P, Anderson J. Obstacles to high-dimensional particle filtering. Monthly Weather Review. 2008;136(12):4629–4640. doi:10.1175/2008MWR2529.1
  21. Pitt MK, Shephard N. Filtering via simulation: auxiliary particle filters. Journal of the American Statistical Association. 1999;94(446):590–599. doi:10.1080/01621459.1999.10474153
  22. Del Moral P, Doucet A, Jasra A. Sequential Monte Carlo samplers. Journal of the Royal Statistical Society: Series B. 2006;68(3):411–436. doi:10.1111/j.1467-9868.2006.00553.x
  23. Herbst E, Schorfheide F. Tempered particle filtering. Journal of Econometrics. 2019;210(1):26–44. doi:10.1016/j.jeconom.2018.11.003
  24. Guarniero P, Johansen AM, Lee A. The iterated auxiliary particle filter. Journal of the American Statistical Association. 2017;112(520):1636–1647. doi:10.1080/01621459.2016.1222291
  25. Beskos A, Crisan D, Jasra A. On the stability of sequential Monte Carlo methods in high dimensions. Annals of Applied Probability. 2014;24(4):1396–1445. doi:10.1214/13-AAP951
  26. Kantas N, Beskos A, Jasra A. Sequential Monte Carlo methods for high-dimensional inverse problems: a case study for the Navier–Stokes equations. SIAM/ASA Journal on Uncertainty Quantification. 2014;2(1):464–489. doi:10.1137/130930364
  27. Prem K, van Zandvoort K, Klepac P, et al. Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the COVID-19 era. PLOS Computational Biology. 2021;17(7):e1009098. doi:10.1371/journal.pcbi.1009098
  28. Butcher JC. Runge–Kutta methods. In: Numerical Methods for Ordinary Differential Equations. John Wiley & Sons; 2016:143–331. doi:10.1002/9781119121534.ch3